23 Sep 2026, 08:47 IST
Emcure Pharmaceuticals Limited
Motilal Oswal Financial Services Ltd. (MOFSL) · Buy · target 2300
The note lists Emcure Pharma as a Focus Investment Idea with a BUY rating and target of Rs 2300.
From MOStMarketOutlook23092026, written by Motilal Oswal Financial Services Ltd. (MOFSL) and hosted by Investment Guru India. Orivam summarised it; the view is Motilal Oswal Financial Services Ltd. (MOFSL)'s, not Orivam's.
Open the original PDF on Investment Guru India →Research PDFs are often removed by the firms that publish them. The summary above is kept so this page still means something if that happens.